Crystallization of eIF4E complexed with eIF4GI peptide and glycerol reveals distinct structural differences around the cap-binding site
- PMID: 19440045
- DOI: 10.4161/cc.8.12.8742
Crystallization of eIF4E complexed with eIF4GI peptide and glycerol reveals distinct structural differences around the cap-binding site
Erratum in
- Cell Cycle. 2010 Oct 1; 9(19):4031
Abstract
An X-ray crystal structure of the eIF4E peptide complex is described in which two such complexes are located in the asymmetric unit. One of these complexes has m(7)GTP bound in a conformation which has been observed in several eIF4E crystal structures, whilst the other complex is free of m(7)GTP and contains a unique glycerol. The two complexes show significant structural differences between each other in the cap-binding site. The glycerol bound structure shows a reorientation of the W102 side chain out of the cap-binding site, disordering of the W56 containing loop and rotation of the carboxyl side-chain of E103. This is accompanied by movement of the M101 side chain into a position where W56 in the m(7)GTP bound complex would otherwise occupy. Rotation of the W102 sidechain also displaces a structured water molecule to a new site. This novel conformation of eIF4E with glycerol bound is hypothesized to be an intermediate state between the apo and m(7)GTP bound forms of eIF4E. These insights should prove useful in the design of inhibitors of eIF4E for cancer therapy.
Similar articles
-
Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.J Mol Biol. 2002 Jun 7;319(3):615-35. doi: 10.1016/S0022-2836(02)00328-5. J Mol Biol. 2002. PMID: 12054859
-
Requirement of RNA binding of mammalian eukaryotic translation initiation factor 4GI (eIF4GI) for efficient interaction of eIF4E with the mRNA cap.Mol Cell Biol. 2009 Mar;29(6):1661-9. doi: 10.1128/MCB.01187-08. Epub 2008 Dec 29. Mol Cell Biol. 2009. PMID: 19114555 Free PMC article.
-
Folding transitions during assembly of the eukaryotic mRNA cap-binding complex.J Mol Biol. 2006 Mar 3;356(4):982-92. doi: 10.1016/j.jmb.2005.12.034. Epub 2005 Dec 27. J Mol Biol. 2006. PMID: 16405910
-
Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives.J Mol Biol. 2007 Sep 7;372(1):7-15. doi: 10.1016/j.jmb.2007.06.033. Epub 2007 Jun 15. J Mol Biol. 2007. PMID: 17631896 Review.
-
Cap in hand: targeting eIF4E.Cell Cycle. 2009 Aug 15;8(16):2535-41. doi: 10.4161/cc.8.16.9301. Epub 2009 Aug 17. Cell Cycle. 2009. PMID: 19597330 Review.
Cited by
-
Crystal structure of a minimal eIF4E-Cup complex reveals a general mechanism of eIF4E regulation in translational repression.RNA. 2012 Sep;18(9):1624-34. doi: 10.1261/rna.033639.112. Epub 2012 Jul 25. RNA. 2012. PMID: 22832024 Free PMC article.
-
Structure-based mutational analysis of eIF4E in relation to sbm1 resistance to pea seed-borne mosaic virus in pea.PLoS One. 2011 Jan 24;6(1):e15873. doi: 10.1371/journal.pone.0015873. PLoS One. 2011. PMID: 21283665 Free PMC article.
-
NMR analysis of the interaction of picornaviral proteinases Lb and 2A with their substrate eukaryotic initiation factor 4GII.Protein Sci. 2015 Dec;24(12):1979-96. doi: 10.1002/pro.2807. Epub 2015 Oct 4. Protein Sci. 2015. PMID: 26384734 Free PMC article.
-
Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1.Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4036-45. doi: 10.1073/pnas.1512118112. Epub 2015 Jul 13. Proc Natl Acad Sci U S A. 2015. PMID: 26170285 Free PMC article.
-
Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?Leuk Lymphoma. 2010 Oct;51(10):1805-15. doi: 10.3109/10428194.2010.496506. Leuk Lymphoma. 2010. PMID: 20629523 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous